Answers are grounded in this paper and cite their sources.
Antibiotic treatment is often compromised by bacterial persistence within biofilms and host cells, contributing to recurrent infections and antimicrobial resistance.Here, a structurally diverse series of N-isopropylacrylamide (NIPAM)-based nanogels (NGs) is evaluated to deliver ceftiofur (CF) against Staphylococcus aureus , using bovine mastitis as a clinically relevant context. Surface chemistry and network architecture are varied to determine how NG structure influences biological interactions and antibiotic performance. Although NIPAM-based NGs are not bactericidal, their composition modulates bacterial surface hydrophobicity and biofilm formation, as well as macrophage inflammatory responses and cellular uptake. CF-NG formulations exhibit strong activity against established biofilms and intracellular S. aureus, with all formulations reducing intracellular bacterial burdens by at least two log units. Cationic NGs enable CF to reduce viable intracellular bacteria to undetectable levels despite the lower cellular uptake observed for cationic NGs without CF. Anionic NGs provide the most balanced profile, combining favorable cytocompatibility, broad immunomodulatory effects, high uptake, and strong antibiofilm and intracellular activity. Overall, the results establish NG structure as a key determinant of interactions with bacteria and host cells and of CF-NG efficacy, providing design principles for nanocarriers targeting biofilm-associated and intracellular S. aureus.
No takes yet. Share an insight, caveat, or question.
Lillo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: